secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2024-07-16T23:59:59+00:00
Accession:  0000950170-24-083764
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics to effect 1-for-10 reverse stock split on July 17, 2024
----------------------------------------------------------------------------

- Board approved 1-for-10 reverse split; authorized by shareholders on June 6, 2024.
- Effective 5:00 p.m. ET July 17, 2024; every 10 pre-split shares become 1 share.
- Stock to trade on Nasdaq under symbol TCRT with new CUSIP 98973P309.
- Equiniti Trust Company appointed as exchange agent for the split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017024083764/0000950170-24-083764-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017024083764/tcrt-20240716.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-083764

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer